ArticleBriefings in bioinformatics2025
Cancer gene identification through integrating causal prompting large language model with omics data-driven causal inference.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives.Breast cancer research : BCR · 2026Review
- Performance comparison of large language models in boron neutron capture therapy knowledge assessment.Scientific reports · 2026Article
- Large language models in emergency and critical care medicine: a comprehensive review of applications, challenges, and future directions.Burns & trauma · 2026Review
- The potential of large language models to advance precision oncology.EBioMedicine · 2025Review
- Large language models in clinical nutrition: an overview of its applications, capabilities, limitations, and potential future prospects.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Identifying genes causally linked to cancer from a multi-omics perspective is essential for understanding the mechanisms of cancer and improving therapeutic strategies. Traditional statistical and machine-learning methods that rely on generalized correlation approaches to identify cancer genes often produce redundant, biased predictions with limited interpretability, largely due to overlooking confounding factors, selection biases, and the nonlinear activation function in neural networks. In this study, we introduce a novel framework for identifying cancer genes across multiple omics domains, named ICGI (Integrative Causal Gene Identification), which leverages a large language model (LLM) prompted with causality contextual cues and prompts, in conjunction with data-driven causal feature selection. This approach demonstrates the effectiveness and potential of LLMs in uncovering cancer genes and comprehending disease mechanisms, particularly at the genomic level. However, our findings also highlight that current LLMs may not capture comprehensive information across all omics levels. By applying the proposed causal feature selection module to transcriptomic datasets from six cancer types in The Cancer Genome Atlas and comparing its performance with state-of-the-art methods, it demonstrates superior capability in identifying cancer genes that distinguish between cancerous and normal samples. Additionally, we have developed an online service platform that allows users to input a gene of interest and a specific cancer type. The platform provides automated results indicating whether the gene plays a significant role in cancer, along with clear and accessible explanations. Moreover, the platform summarizes the inference outcomes obtained from data-driven causal learning methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.